Cancer Related Fatigue in Patients Receiving Chemotherapy
NCT00261534 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2006-09-14
Summary
The purpose of this study is to examine the degree of fatigue in patients receiving chemotherapy. Special interest goes out to the course of fatigue throughout five treatments and the actions taken by patients to reduce this fatigue.The correlation between fatigue and haemoglobin will also be subject of study.
Conditions
Sponsors & Collaborators
-
Medical Center Alkmaar
lead OTHER
Principal Investigators
-
D. Hilarius, MSc · Medical Centre Alkmaar, Hospital Pharmacy
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-01-31
- Completion
- 2006-07-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Modafinil in Treating Fatigue in Patients Receiving Chemotherapy for Cancer
NCT00042848 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer Patients
NCT00516269 ·Status: TERMINATED ·Phase: PHASE3
-
Safety and Efficacy of ALC in Breast Cancer in Subjects With Fatigue
NCT00555841 ·Status: TERMINATED ·Phase: PHASE2
-
The Analysis of Fatigue on Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukaemia
NCT06233890 ·Status: ACTIVE_NOT_RECRUITING
-
Nutritional Risk and Mucositis in Patients With Head and Neck Carcinoma Receiving Chemoradiation
NCT00577902 ·Status: COMPLETED
-
Patient Controlled Administration of Methylphenidate for Cancer Related Fatigue - PRN Methylphenidate
NCT02361125 ·Status: COMPLETED ·Phase: PHASE1
-
Collaborative Network to Take Responsibility for Oral Anticancer Therapy
NCT02861209 ·Status: UNKNOWN ·Phase: NA
-
Statin Therapy in Young Adult Survivors of Childhood Cancer
NCT01733953 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of AND017 in Cancer Related Anemic Patients Receiving Chemotherapy
NCT06075030 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid Tumors
NCT03035409 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing Chemo
NCT00775645 ·Status: COMPLETED ·Phase: PHASE3
-
Developmental Study on Fatigue in Cancer
NCT00034450 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Synthetic Thyrotropin Releasing Hormone (TRH) as a Treatment for Cancer-related Fatigue
NCT00790296 ·Status: TERMINATED ·Phase: PHASE2
-
Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue
NCT06482515 ·Status: RECRUITING ·Phase: PHASE2
-
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer
NCT05183126 ·Status: RECRUITING ·Phase: PHASE4
-
Effect of Ketamine on Fatigue Following Cancer Therapy
NCT02317341 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Modafinil to Reduce Persistent Fatigue in Patients Following Treatment for Cancer
NCT00178373 ·Status: COMPLETED ·Phase: PHASE2
-
Thymosin-α1 in Cancer-Related Fatigue
NCT02127268 ·Status: UNKNOWN ·Phase: PHASE3
-
Cancer-related Fatigue in Patients With Breast Cancer Treatment With Zhengyuan Capsules
NCT06381557 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Improving the Safety of Fluoropyrimidine-based Chemotherapy
NCT04194957 ·Status: UNKNOWN ·Phase: NA
-
A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients
NCT00659269 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With Fluoropyrimidines
NCT00838370 ·Status: COMPLETED ·Phase: PHASE1
-
Mechanisms and Predictors of Unusual Radiation or Chemotherapy Toxicity
NCT02469194 ·Status: WITHDRAWN
-
Studying Fentanyl in Patients With Cancer
NCT00899951 ·Status: TERMINATED
-
The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue)
NCT07151391 ·Status: RECRUITING ·Phase: PHASE2